Abstract:The porcine reproductive and respiratory syndrome virus (PRRSV) has three major structural proteins which designated as GP5, M, and N. Protein GP5 and M have been considered very important to arouse the humoral and cellular immune responses against PRRSV infection and proposed to be the excellent candidate proteins in the design of PRRS bioengineering vaccine. There were some attempts on expressing GP5 or M in DNA vaccine and adenovirus to arouse humoral and cellular immune responses, but few papers have been reported on that the immune response can be difference because of the expression patterns of GP5 and M proteins in the recombinant virus. In this article, four recombinant viruses that expressed GP5 and M proteins of PRRSV in the modified vaccinia virus ankara (MVA) with different expression patterns were made. In these recombinant virus (rMVAs), GP5 and M proteins were expressed in MVA in the same virus but under the control of two promoters (rMVA-GP5/M), or as a fusion protein under one promoter (rMVA-GP5-M), or separately (rMVA-GP5 and rMVA-M). The humoral and cellular immune responses for the four recombinant viruses were evaluated with mouse model. Every mouse was inoculated with 5 x 10(5) TCID50 of the different rMVAs and boosted 3 weeks later. Neutralizing antibody titers for each group were detected with virus neutralization test assay weekly after the primary inoculation for 13 weeks to evaluate the humoral immune response. The production of gamma interferon (IFN-gamma), interleukin-2 (IL-2), and interleukin-4 (IL-4) was detected in splenocytes of rMVA-inoculated mice at 30, 60, and 90 days post inoculation to evaluate the cellular immune response. Results showed that rMVA-GP5 and rMVA-M cannot induce obvious humoral and cellular immune responses; rMVA-GP5-M inoculated group developed better immune responses than rMVA-GP5 and rMVA-M inoculated groups; however, mice inoculated with rMVA-GP5/M maintained the strongest cellular response against PRRS and consistently enhanced the anti-PRRSV humoral responses. The strategy of co-expressing PRRSV GP5 and M protein in MVA under the control of different promoters might be an attractive method for future PRRSV vaccine design.

Vaccination of Mice with ORF5 Plasmid DNA of PRRSV; Enhanced Effects by Co-Immunizing with Porcine IL-15.

Enhanced Immune Responses of Mice Inoculated Recombinant Adenoviruses Expressing GP5 by Fusion with GP3 And/or GP4 of PRRS Virus

Study on Immunological Responses to Porcine Reproductive and Respiratory Syndrome Virus DNA Vaccines Co-expressing Modified GP5 (gp5m) and M Proteins

Recombinant Adenovirus Expressing GP5 and M Fusion Proteins of Porcine Reproductive and Respiratory Syndrome Virus Induce Both Humoral and Cell-Mediated Immune Responses in Mice.

Immunization of mice with recombinant DNA vaccines encoding PRRSV GP5 gene

Immune Responses of Mice Immunized by DNA Plasmids Encoding PCV2 ORF 2 Gene, Porcine IL-15 or the Both

Highly Efficient Expression of Interleukin-2 under the Control of Rabbit Beta-Globin Intron Ii Gene Enhances Protective Immune Responses of Porcine Reproductive and Respiratory Syndrome (prrs) Dna Vaccine in Pigs

The mRNA Vaccine Expressing Single and Fused Structural Proteins of Porcine Reproductive and Respiratory Syndrome Induces Strong Cellular and Humoral Immune Responses in BalB/C Mice

Positive effects of porcine IL-2 and IL-4 on virus-specific immune responses induced by the porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 DNA vaccine in swine

DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity.

Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene

A Suicidal Dna Vaccine Co-Expressing Two Major Membrane-Associated Proteins of Porcine Reproductive and Respiratory Syndrome Virus Antigens Induce Protective Responses

GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge.

Vaccination of Mice with Listeria ivanovii Expressing the Truncated M Protein of Porcine Reproductive and Respiratory Syndrome Virus Induces both Antigen-Specific CD4+ and CD8+ T Cell-Mediated Immunity

Immunogenicity and Protective Efficacy of Recombinant Pseudorabies Virus Expressing the Two Major Membrane-Associated Proteins of Porcine Reproductive and Respiratory Syndrome Virus

Immunogenicity of the Glycoprotein 5 Truncated Trans-Membrane Regions of Porcine Reproductive and Respiratory Syndrome Virus

Co-expressing GP5 and M Proteins under Different Promoters in Recombinant Modified Vaccinia Virus Ankara (Rmva)-Based Vaccine Vector Enhanced the Humoral and Cellular Immune Responses of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)

Enhanced Humoral Immune Response of DNA Vaccine Composing a Modified ORF5 Gene of Porcine Reproductive and Respiratory Syndrome Virus

Porcine GPX1 enhances GP5-based DNA vaccination against porcine reproductive and respiratory syndrome virus

Construction of recombinant plasmid pcDNA4.0-ORF6-ORF3-ORF5 of PRRSV and humoral immunity induced by the plasmid in mice

Construction and Immunogenicity of Recombinant Expression Vectors for GP5 and M Proteins of Porcine Reproductive and Respiratory Syndrome Virus